1,4-Diphenylpyrazolin-5-on

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 1,4-Diphenylpyrazolin-5-on
• 英文别名: 2,4-diphenyl-1,2-dihydro-pyrazol-3-one；2,4-Diphenyl-1,2-dihydro-pyrazol-3-on；2,4-diphenyl-1H-pyrazol-3-one
• 化学式: C₁₅H₁₂N₂O
• 分子量: 236.273
• InChiKey: XNWYPYFQYFUUTE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  32.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  Alpha-甲酰基苯乙酸乙酯 在 盐酸 、 乙醇 作用下， 生成 1,4-Diphenylpyrazolin-5-on
  参考文献：
  名称：

  Wislicenus, Chemische Berichte, 1895, vol. 28, p. 773

  摘要：

  DOI：

文献信息

• SUBSTITUTED DIHYDROPYRAZOLONES AND THEIR USE
  申请人：Jeske Mario

  公开号：US20090269420A1

  公开（公告）日：2009-10-29

  The present application relates to novel substituted dihydropyrazolone derivatives, processes for their preparation, their use for treatment and/or prophylaxis of diseases and their use for the preparation of medicaments for treatment and/or prophylaxis of diseases, in particular cardiovascular and haematological diseases and kidney diseases, and for promoting wound healing.

  本申请涉及新颖的取代二氢吡唑酮衍生物，其制备方法，它们用于治疗和/或预防疾病的用途，以及用于制备治疗和/或预防疾病的药物，特别是心血管和血液疾病、肾脏疾病以及促进伤口愈合的用途。
• SUBSTITUTED DIHYDROPYRAZOLONES FOR TREATING CARDIOVASCULAR AND HEMATOLOGICAL DISEASES
  申请人：Thede Kai

  公开号：US20100305085A1

  公开（公告）日：2010-12-02

  The invention relates to dihydropyrazolon-derivatives of formula (I), to methods for their production, to their use for treating and/or for preventing diseases and their use for producing medicaments for treating and/or for preventing diseases, in particular cardiovascular and haematological diseases, kidney diseases and for promoting the healing of wounds.

  这项发明涉及式(I)的二氢吡唑酮衍生物，以及它们的生产方法，它们用于治疗和/或预防疾病以及用于生产治疗和/或预防疾病的药物，特别是心血管和血液疾病、肾脏疾病以及促进伤口愈合的用途。
• SUBSTITUTED DIHYDROPYRAZOLONES AND USE THEREOF AS HIF-PROLYL-4 -HYDROXYLASE INHIBITORS
  申请人：Thede Kai

  公开号：US20120264704A1

  公开（公告）日：2012-10-18

  The present application relates to novel substituted dihydropyrazolone derivatives, processes for their preparation, their use for treatment and/or prophylaxis of diseases and their use for the preparation of medicaments for treatment and/or prophylaxis of diseases, in particular cardiovascular and hematological diseases and kidney diseases, and for promoting wound healing.

  本申请涉及新颖的取代二氢吡唑酮衍生物，其制备方法，其用于治疗和/或预防疾病的用途，以及用于制备治疗和/或预防疾病的药物，特别是心血管和血液病以及肾脏疾病，并促进伤口愈合。
• SUBSTITUTED DIPYRIDYL-DIHYDROPYRAZOLONES AND USE THEREOF
  申请人：Thede Kai

  公开号：US20100093803A1

  公开（公告）日：2010-04-15

  The present application relates to novel substituted dipyridyldihydropyrazolone derivatives, processes for their preparation, their use for treatment and/or prophylaxis of diseases and their use for the preparation of medicaments for treatment and/or prophylaxis of diseases, in particular cardiovascular and hematological diseases and kidney diseases, and for promoting wound healing.

  本申请涉及新型取代二吡啶基二氢吡唑酮衍生物，其制备过程，其用于治疗和/或预防疾病以及其用于制备治疗和/或预防疾病的药物，特别是心血管和血液学疾病、肾脏疾病以及促进伤口愈合的药物。
• CONTRIBUTION TO THE STUDY OF PYRAZOLONES
  作者：Paul E. Gagnon、Jean L. Boivin、Méüde Tremblay

  DOI：10.1139/v53-090

  日期：1953.7.1

  opyrazole yielded 1,4-diphenyl-5-aminopyrazole by hydrolysis and decarboxylation. The phenylhydrazone of ethyl phenyloxalacetate gave a pyrazolone which was transformed into 1,4-diphenyl-3-amino-5-pyrazolone. The 2,4-diphenyl-3-amino-5-pyrazolone was obtained from ethyl phenylcyanoacetate and phenylhydrazine by heating in acetic acid. 4-Alkyl-3-hydroxy- and 3-amino-5-pyrazolones and 4,4-dialkyl-3-oxo-

  1,4-二苯基-3-carbethoxy-5-氨基吡唑通过水解和脱羧产生1,4-二苯基-5-氨基吡唑。苯基草乙酸乙酯的苯腙生成吡唑啉酮，后者转化为 1,4-二苯基-3-氨基-5-吡唑啉酮。2,4-二苯基-3-氨基-5-吡唑啉酮是由苯基氰基乙酸乙酯和苯肼通过在乙酸中加热得到的。4-烷基-3-羟基-和 3-氨基-5-吡唑啉酮和 4,4-二烷基-3-氧代-和 3-亚氨基-5-吡唑啉酮，在 2 位被碳酰氨基或 α- 或 β-萘基取代, 由单取代或双取代的丙二酸乙酯和氰基乙酸乙酯、4-苯基氨基脲以及α-和β-萘基肼制备。在中性和酸性溶液中测定紫外吸收光谱。